PLRZ · Polyrizon Ltd.
$11.48
+0.22 (+1.95%)
At close · Jul 29
Market Cap
$18.11M
Shares
1.61M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.26
Open$13.85
Day$10.31–13.88
52W$2.88–18.20
Avg vol 30d51K
Short int50K · 3.1% float · 1.0d
Short vol59%
DataOct 2024–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−4%
below
Price vs 50-day avg
−17%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
55%
mid-range
Momentum
relative strength
1-month return
−12%
trailing
6-month return
−29%
trailing
YTD return
+33%
this year
Relative strength
−36%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow
Accumulating
+33% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.10% of float · ▲ +23.0% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
4 holders — 13F breadth
Squeeze score
43
elevated · 0–100
Fundamentals
EPS growth
−99%
Y/Y
Free cash flow
$-4.5M
Balance sheet
$1.3M
net cash
Quant / Vol
risk profile
Volatility
205%
annualized · 1-yr
Max drawdown
−64%
past year
ATR
15.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−4%
Neutral
Price vs 50-day avg
−17%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
55%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow
Accumulating
+33% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.10% of float · ▲ +23.0% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
4 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $3
Now $11 · 55%
52-wk high $18
vs 200-day avg -4%
vs 50-day avg -17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLRZ
this stock
Polyrizon Ltd.
|
$18.11M | +32.6% | — | — | 3.1% |
|
ONC
BeOne Medicines Ltd.
|
$474.96B | +8.8% | +22179.2% | 966.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
4
- % held
- 2.2%
- Net QoQ
- +20.8K sh
- Top holder
- FNY Investment Advisers,…
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLRZ | -16.5% | -11.7% | -28.6% | -10.1% | +32.6% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -15.5% | -11.7% | -36.0% | -9.3% | +24.0% |